"AIDS Dementia Complex" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A neurologic condition associated with the ACQUIRED IMMUNODEFICIENCY SYNDROME and characterized by impaired concentration and memory, slowness of hand movements, ATAXIA, incontinence, apathy, and gait difficulties associated with HIV-1 viral infection of the central nervous system. Pathologic examination of the brain reveals white matter rarefaction, perivascular infiltrates of lymphocytes, foamy macrophages, and multinucleated giant cells. (From Adams et al., Principles of Neurology, 6th ed, pp760-1; N Engl J Med, 1995 Apr 6;332(14):934-40)
| Descriptor ID |
D015526
|
| MeSH Number(s) |
C02.782.815.616.400.070 C02.800.801.400.070 C10.228.140.380.070 C20.673.480.070 F03.615.400.050
|
| Concept/Terms |
AIDS Dementia Complex- AIDS Dementia Complex
- Complex, AIDS Dementia
- Dementia Complex, AIDS
- HIV-Associated Cognitive Motor Complex
- HIV Associated Cognitive Motor Complex
- Dementia Complex, Acquired Immune Deficiency Syndrome
- Acquired-Immune Deficiency Syndrome Dementia Complex
- AIDS-Related Dementia Complex
- AIDS Related Dementia Complex
- HIV Dementia
- Dementia, HIV
- Dementias, HIV
- HIV Dementias
- Dementia Complex, AIDS-Related
- Complex, AIDS-Related Dementia
- Dementia Complex, AIDS Related
HIV Encephalopathy- HIV Encephalopathy
- Encephalopathies, HIV
- HIV Encephalopathies
- Encephalopathy, AIDS
- Encephalopathy, HIV
- AIDS Encephalopathy
- AIDS Encephalopathies
- Encephalopathies, AIDS
|
Below are MeSH descriptors whose meaning is more general than "AIDS Dementia Complex".
Below are MeSH descriptors whose meaning is more specific than "AIDS Dementia Complex".
This graph shows the total number of publications written about "AIDS Dementia Complex" by people in this website by year, and whether "AIDS Dementia Complex" was a major or minor topic of these publications.
View timeline visualization
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 14 | 1 | 15 |
| 1996 | 15 | 4 | 19 |
| 1997 | 4 | 1 | 5 |
| 1998 | 9 | 0 | 9 |
| 1999 | 10 | 1 | 11 |
| 2000 | 5 | 3 | 8 |
| 2001 | 7 | 1 | 8 |
| 2002 | 10 | 2 | 12 |
| 2003 | 8 | 1 | 9 |
| 2004 | 19 | 2 | 21 |
| 2005 | 13 | 4 | 17 |
| 2006 | 14 | 5 | 19 |
| 2007 | 21 | 5 | 26 |
| 2008 | 14 | 4 | 18 |
| 2009 | 17 | 4 | 21 |
| 2010 | 13 | 3 | 16 |
| 2011 | 15 | 2 | 17 |
| 2012 | 14 | 2 | 16 |
| 2013 | 19 | 1 | 20 |
| 2014 | 19 | 1 | 20 |
| 2015 | 21 | 2 | 23 |
| 2016 | 8 | 3 | 11 |
| 2017 | 26 | 1 | 27 |
| 2018 | 20 | 3 | 23 |
| 2019 | 10 | 2 | 12 |
| 2020 | 10 | 2 | 12 |
| 2021 | 11 | 0 | 11 |
| 2022 | 3 | 0 | 3 |
| 2023 | 3 | 0 | 3 |
| 2024 | 0 | 4 | 4 |
Below are the most recent publications written about "AIDS Dementia Complex" by people in Profiles.
-
Switching to Low Neurotoxic Antiretrovirals to Improve Neurocognition Among People Living With HIV-1-Associated Neurocognitive Disorder: The MARAND-X Randomized Clinical Trial. J Acquir Immune Defic Syndr. 2024 Oct 01; 97(2):180-191.
-
Changes in cerebrospinal fluid proteins across the spectrum of untreated and treated chronic HIV-1 infection. PLoS Pathog. 2024 Sep; 20(9):e1012470.
-
Awareness and Knowledge of HIV-Associated Neurocognitive Disorder Among Middle-Aged and Older People Living With HIV/AIDS in Southern Nevada: Implications for HIV/AIDS Community-Based Education Programs. AIDS Educ Prev. 2024 04; 36(2):141-154.
-
Host single nucleotide polymorphisms and biomarkers of neuronal damage and inflammation in people living with HIV. Int J Antimicrob Agents. 2024 Jun; 63(6):107137.
-
The clinical utility of three frailty measures in identifying HIV-associated neurocognitive disorders. AIDS. 2024 04 01; 38(5):645-655.
-
Alterations in glutamate, arginine, and energy metabolism characterize cerebrospinal fluid and plasma metabolome of persons with HIV-associated dementia. AIDS. 2024 03 01; 38(3):299-308.
-
Differential expression of interferon-induced protein with tetratricopeptide repeats 3 (IFIT3) in Alzheimer's disease and HIV-1 associated neurocognitive disorders. Sci Rep. 2023 02 25; 13(1):3276.
-
Cerebrospinal Fluid Viral Load Across the Spectrum of Untreated Human Immunodeficiency Virus Type 1 (HIV-1) Infection: A Cross-Sectional Multicenter Study. Clin Infect Dis. 2022 08 31; 75(3):493-502.
-
Higher Cerebrospinal Fluid Soluble Urokinase-type Plasminogen Activator Receptor, But Not Interferon γ-inducible Protein 10, Correlate With Higher Working Memory Deficits. J Acquir Immune Defic Syndr. 2022 05 01; 90(1):106-114.
-
Clinical characteristics and outcomes after new-onset seizure among Zambian children with HIV during the antiretroviral therapy era. Epilepsia Open. 2022 06; 7(2):315-324.